Announcement of Rory Riggs's appointment as CEO of Cibus, naming him a pioneer in Systems Economics.
Cibus Appoints Co-Founder Rory Riggs as Chief Executive Officer
Coverage of the Cibus/Calyxt merger closing, including a Riggs quote on the combined company's patent portfolio.
Cibus named #2 Most Innovative Company in agriculture for 2024, with a quote from Riggs.
Cibus Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
Announcement of Riggs's transition from CEO to Chairman of the Board at Cibus as Craig Wichner becomes CEO.
Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer
Coverage of the Cibus Oberlin facility opening, including Riggs's quote on applying pharmaceutical quality standards to plant biology.
Cibus Opens Gene Editing Facility for Trait Production
Authored article by Rory Riggs on precision gene editing and its application to agricultural trait development.
Gene Editing to Lead a New Agricultural Revolution
Margaret Crotty and Rory Riggs Health Care Leadership Award, 2024
Proposed Merger Shows That When it Comes to Gene Editing, You Ain’t Seen Nothing Yet
Coverage of an open letter authored by Riggs as Royalty Pharma Chairman to the Elan board.
Royalty Pharma Co-Founder Writes Open Letter to Board of Elan Ahead of EGM
Launch announcement with a direct quote from Riggs on ESG analytics.
Syntax LLC Announces Launch of Stratified LargeCap ESG Index
Op-ed authored by Rory Riggs articulating the case for functional, systems-based classification of economic data as an alternative to conventional sector-based risk models.
Commentary: Systems Economics — A New Prescription for Risk Management
Systems Economics: A New Prescription for Risk Management
Inventor of the coordinate-based Locus Model and Functional Information System for classifying economic activity by function rather than conventional industry category.
Built the Syntax Stratified Indices, benchmark indices constructed on functional rather than conventional sector classification.
Index construction and portfolio classification
Managing Director in M&A at PaineWebber, 1981–1990.
Founded and built Royalty Pharma into the world's largest acquirer of pharmaceutical royalties, helping create the category as an investable asset class.
Led Cibus's application of production-system methodology to plant biology through the Rapid Trait Development System.
Precision gene editing / agricultural biotechnology
Managing Member of Balfour Venture Partners.
President, CFO, and Director at BioMatrix Inc.
President, CFO, and Director of BioMatrix (NYSE: BMX), overseeing the launch of Synvisc, a viscosupplementation treatment.
Chairman of the Board at Cibus Global, Ltd.
Transitioned from Chief Executive Officer to Chairman of the Board in June 2026 as Craig Wichner became CEO.
Chief Executive Officer at Cibus Global, Ltd.
Co-founder and CEO of Cibus, the leading precision gene-editing company for agriculture. Applied the Locus Model's functional-systems approach to plant biology through the Rapid Trait Development System (RTDS).
Chair of eReceivables, a healthcare service technology company.
Managing Director, Mergers & Acquisitions at PaineWebber Inc.
Managing Director in the mergers and acquisitions group at PaineWebber.
Managing Director, Mergers & Acquisitions
Chief Executive Officer at RF&P Corporation
CEO of RF&P, a real estate investment company owned by the Virginia State Retirement System.
Chairman and Founder at Royalty Pharma plc
Co-founded Royalty Pharma in 1996 with a $60 million start; built it into the world's largest acquirer of pharmaceutical royalties, holding partial royalty rights on seven of the top thirty drugs sold in the United States. Served as Chairman from 2003 and resigned as a director on June 6, 2024.
General Partner and co-founder of Scientia Ventures.
Executive Chairman / Founder at Syntax Data (Syntax LLC / Locus Analytics)
Founded Locus Analytics in 2009 as an economic research firm to pioneer Systems Economics and develop and patent the Functional Information System. Syntax and Locus Analytics merged in March 2023. Built the coordinate-based Locus Model and FIS information infrastructure for finance and economic data, and the Syntax Stratified Indices.
CEO and Trustee at WEBS ETF Trust (Syntax ETF Trust)
CEO and Trustee of the Syntax-affiliated ETF trust since 2017.
Angel investor and board member of the fintech company Bond Street Marketplace.
Director of the Feinstein Institute, the research arm of Northwell Health.
Board Chair and director of GeneNews, later StageZero Life Sciences, since 1998.
Director of Intra-Cellular Therapies from January 2014, serving on the Audit Committee.
Co-founder and director of FibroGen since October 1993 — his longest confirmed board tenure.
Kyntra Bio (formerly known as FibroGen Inc.)
Director of the New York Genome Center, his primary current nonprofit board.
Syntax Data (Syntax LLC / Locus Analytics)
Rory Riggs is an inventor, executive, and investor who applies one system, the Locus Model, across biotechnology, finance, and economics. Mr. Riggs is Executive Chairman of Syntax Data, which has built a foundational coordinate-based information infrastructure for finance and economic data based on his patented Locus Model and Functional Information System (FIS).
Rory Riggs is an inventor, executive, and investor who applies one system, the Locus Model, across biotechnology, finance, and economics.
President, CFO, and Director, 1996–2000; oversaw the launch of Synvisc.
Co-founder; CEO 2021–2026, then Chairman of the Board.
Current director of the research arm of Northwell Health.
Co-founder and director since October 1993.
Managing Director, Mergers & Acquisitions, 1981–1990.
CEO, 1991–1995, a Virginia State Retirement System–owned real estate investment company.
Co-founder and Chairman (2003–2024); built the pharmaceutical royalty asset class.
Founder and Executive Chairman; built the Locus Model, Functional Information System, and Syntax Stratified Indices.
The personal site of Rory Riggs — inventor of the Locus Model and Functional Coordinates, founder of Systems Economics, and Executive Chairman of Syntax Data. Documents his work across financial classification (FIS, Syntax Stratified Indices), agricultural biotechnology (Cibus, Rapid Trait Development System), and pharmaceutical royalties (Royalty Pharma).
The coordinate system that locates any economic activity or resource by the function it performs and its position in the order of work. The construct is deliberately parallel to latitude and longitude in physical space and to date and hour in time: it supplies the missing third reference frame, answering what where the other two answer where and when. Every data entity in a functional information system is tagged with functional coordinates, so that function can be used as an index — to relate attributes across entities and to measure functional proximity, exactly as geographic coordinates do for spatial data. Source: US 9,910,910 · US 10,019,509.